185 related articles for article (PubMed ID: 20459787)
1. Natural killer cells control a T-helper 1 response in patients with Behçet's disease.
Yamaguchi Y; Takahashi H; Satoh T; Okazaki Y; Mizuki N; Takahashi K; Ikezawa Z; Kuwana M
Arthritis Res Ther; 2010; 12(3):R80. PubMed ID: 20459787
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells dominate a Th-1 polarized response in Behçet's disease patients with uveitis.
Kucuksezer UC; Aktas-Cetin E; Bilgic-Gazioglu S; Tugal-Tutkun I; Gül A; Deniz G
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S24-9. PubMed ID: 25937098
[TBL] [Abstract][Full Text] [Related]
3. Imbalance of Th17 to Th1 cells in Behçet's disease.
Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
[TBL] [Abstract][Full Text] [Related]
4. T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris.
Takahashi H; Amagai M; Tanikawa A; Suzuki S; Ikeda Y; Nishikawa T; Kawakami Y; Kuwana M
J Invest Dermatol; 2007 Feb; 127(2):324-30. PubMed ID: 16946717
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
[TBL] [Abstract][Full Text] [Related]
6. Increased Notch pathway activation in Behçet's disease.
Qi J; Yang Y; Hou S; Qiao Y; Wang Q; Yu H; Zhang Q; Cai T; Kijlstra A; Yang P
Rheumatology (Oxford); 2014 May; 53(5):810-20. PubMed ID: 24446471
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cell Subsets and Their Functional Activity in Behçet's Disease.
Cosan F; Aktas Cetin E; Akdeniz N; Emrence Z; Cefle A; Deniz G
Immunol Invest; 2017 May; 46(4):419-432. PubMed ID: 28388249
[TBL] [Abstract][Full Text] [Related]
8. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
9. Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease.
Suzuki N; Nara K; Suzuki T
Clin Med Res; 2006 Jun; 4(2):147-51. PubMed ID: 16809408
[TBL] [Abstract][Full Text] [Related]
10. Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Behçet's disease.
Sallakci N; Tahrali I; Kucuksezer UC; Cetin EA; Gul A; Deniz G
Immunol Res; 2022 Oct; 70(5):654-666. PubMed ID: 35661971
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
12. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.
Frassanito MA; Dammacco R; Cafforio P; Dammacco F
Arthritis Rheum; 1999 Sep; 42(9):1967-74. PubMed ID: 10513814
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease.
Imamura Y; Kurokawa MS; Yoshikawa H; Nara K; Takada E; Masuda C; Tsukikawa S; Ozaki S; Matsuda T; Suzuki N
Clin Exp Immunol; 2005 Feb; 139(2):371-8. PubMed ID: 15654837
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.
Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir M; Feki M; Hamzaoui K
J Autoimmun; 2004 Nov; 23(3):267-73. PubMed ID: 15501397
[TBL] [Abstract][Full Text] [Related]
15. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
16. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
17. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
[TBL] [Abstract][Full Text] [Related]
18. Circulating NK cells and their subsets in Behçet's disease.
Hasan MS; Ryan PL; Bergmeier LA; Fortune F
Clin Exp Immunol; 2017 May; 188(2):311-322. PubMed ID: 28170096
[TBL] [Abstract][Full Text] [Related]
19. Cytokine profile in Behçet's disease patients. Relationship with disease activity.
Hamzaoui K; Hamzaoui A; Guemira F; Bessioud M; Hamza M; Ayed K
Scand J Rheumatol; 2002; 31(4):205-10. PubMed ID: 12369651
[TBL] [Abstract][Full Text] [Related]
20. Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis.
Aktas Cetin E; Cosan F; Kucuksezer UC; Bilgic S; Cagatay Y; Gul A; Deniz G
Rheumatol Int; 2013 Mar; 33(3):733-41. PubMed ID: 22576660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
